全球胚胎着床前基因诊断市场：依类型、最终用户、地区

预计2024年全球胚胎着床前基因诊断市场规模将达5,710万美元，2024年至2031年复合年增长率为7.6%，2031年将达9,510万美元。

图. 2024年各地区胚胎着床前基因诊断市场占有率（%）

胚胎着床前遗传学诊断（PGD）是一种体外受精方法，其中对胚胎着床前胚胎的一个或多个细胞进行切片检查并测试遗传缺陷。 PGD​​有助于识别体外受精造成的胚胎遗传异常，并选择性地移植健康胚胎。 PGD​​可以防止遗传疾病传染给后代，并且可以只选择没有遗传疾病的胚胎。不孕率上升、随着孕产妇年龄增加而增加的染色体异常风险、对预防遗传疾病的兴趣日益浓厚以及PGD技术的进步等因素预计将在预测期内推动全球胚胎着床前遗传诊断市场的成长。的

市场动态：

全球胚胎着床前基因诊断市场的成长是由不孕率上升、对遗传疾病预防的日益关注以及全球孕产妇年龄增加导致染色体异常机会增加所推动的。然而，胚胎着床前基因诊断的局限性、对胚胎着床前基因诊断的社会和伦理问题以及严格的监管可能会阻碍市场的成长。政府和私人组织为传播 PGD 意识而采取的各种倡议可能会提供利润丰厚的市场成长机会。市场相关人员正在转向次世代定序等新技术，以提供全面的染色体筛检并改善结果。

本研究的主要特点

• 该报告对全球胚胎着床前基因诊断市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
• 它揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球胚胎着床前基因诊断市场的主要企业。
• 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
• 全球胚胎着床前基因诊断市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过用于分析全球胚胎着床前基因诊断市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球胚胎着床前基因诊断市场—COVID-19 的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章全球胚胎着床前基因诊断市场，按类型，2019-2031，（百万美元）

• 染色体异常
• 非整倍体
• X连锁疾病
• 单基因疾病
• HLA型检测
• 性别选择
• 其他的

第六章 全球胚胎着床前基因诊断市场，依最终使用者划分，2019-2031 年（百万美元）

• 诊断实验室
• 医院
• 诊所
• 其他的

第七章全球胚胎着床前基因诊断市场，按地区，2019-2031，（百万美元）

• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第八章 竞争格局

• 公司简介
  • PerkinElmer, Inc.
  • Genea Limited
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • CooperSurgical, Inc.
  • Beijing Genomics Institute（BGI）
  • LabCorp of America Holdings（Laboratory Corporation of America）
  • Natera, Inc.
  • Oxford Gene Technology
  • California Pacific Medical Center
  • Good Start Genetics, Inc.
  • Invitae Corporation
  • F. Hoffmann-La Roche AG
  • Progenesis

第九章 分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第10章 参考文献与调查方法

• 参考
• 调查方法

Global preimplantation genetic diagnosis market is estimated to be valued at USD 57.1 Mn in 2024 and is expected to reach USD 95.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.

Figure. Preimplantation Genetic Diagnosis Market Share (%), By Region 2024

Preimplantation genetic diagnosis (PGD) is an in-vitro fertilization procedure in which one or few cells are biopsied from an embryo before implantation and tested for genetic defects. PGD helps to identify genetic defects in embryos developed through IVF and assists in selective implantation of healthy embryos. It aids in preventing the transmission of hereditary disorders to offspring and allows couples to choose only embryos without genetic conditions. Factors such as rising infertility rates, increasing risk of chromosomal abnormalities with advancing maternal age, growing focus on prevention of genetic disorders, and technological advancements in PGD techniques can drive the global preimplantation genetic diagnosis market growth during the forecast period.

Market Dynamics:

Global preimplantation genetic diagnosis market growth is driven by rising infertility rates, growing focus on prevention of genetic disorders, increasing maternal age globally that leads to higher chances of chromosomal abnormalities. However, limitations of PGD, social and ethical concerns regarding PGD, and stringent regulations can hamper the market growth. Various initiatives by government and private organizations to spread awareness about PGD can offer lucrative market growth opportunities. Market players are focusing on new techniques such as next-generation sequencing to provide comprehensive chromosome screening with improved outcomes.

Key Features of the Study:

• This report provides in-depth analysis of the global preimplantation genetic diagnosis market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global preimplantation genetic diagnosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include CooperSurgical, Illumina, Thermo Fisher, Agilent Technologies, PerkinElmer, Abbott Laboratories, Natera, Rubicon Genomics, Oxford Gene Technology, Yikon Genomics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global preimplantation genetic diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preimplantation genetic diagnosis market

Detailed Segmentation-

• By Type:
  • Chromosomal Abnormalities
  • Aneuploidy
  • X-linked diseases
  • Single gene disorders
  • HLA Typing
  • Gender Selection
  • Others
• By End User
  • Diagnostic Laboratories
  • Hospitals
  • Clinics
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • PerkinElmer, Inc.
  • Genea Limited
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • CooperSurgical, Inc.
  • Beijing Genomics Institute (BGI)
  • LabCorp of America Holdings (Laboratory Corporation of America)
  • Natera, Inc.
  • Oxford Gene Technology
  • California Pacific Medical Center
  • Good Start Genetics, Inc.
  • Invitae Corporation
  • F. Hoffmann-La Roche AG
  • Progenesis

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Preimplantation Genetic Diagnosis Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Preimplantation Genetic Diagnosis Market, By Type, 2019 - 2031, (USD Mn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Chromosomal Abnormalities
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Aneuploidy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• X-linked diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Single gene disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• HLA Typing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Gender Selection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Preimplantation Genetic Diagnosis Market, By End User, 2019 - 2031, (USD Mn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Diagnostic Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Preimplantation Genetic Diagnosis Market, By Region, 2019 - 2031, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  • Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • PerkinElmer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Genea Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Quest Diagnostics Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CooperSurgical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Beijing Genomics Institute (BGI)
  • LabCorp of America Holdings (Laboratory Corporation of America)
  • Natera, Inc.
  • Oxford Gene Technology
  • California Pacific Medical Center
  • Good Start Genetics, Inc.
  • Invitae Corporation
  • F. Hoffmann-La Roche AG
  • Progenesis

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact